Implication of miRNA in the diagnosis and treatment of breast cancer

References

• Khoshnaw SM, Green AR, Powe DG, Ellis IO. MicroRNA involvement in the pathogenesis and management of breast cancer. J. Clin. Pathol.62(5), 422–428 (2009).
   PubMed Web of Science ®Google Scholar
• Cifuentes D, Xue H, Taylor DW et al. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science328(5986), 1694–1698 (2010).
   PubMed Web of Science ®Google Scholar
• Chong MM, Zhang G, Cheloufi S, Neubert TA, Hannon GJ, Littman DR. Canonical and alternate functions of the microRNA biogenesis machinery. Genes Dev.24(17), 1951–1960 (2010).
   PubMed Web of Science ®Google Scholar
• Meyers BC, Simon SA, Zhai J. MicroRNA processing: battle of the bulge. Curr. Biol.20(2), R68–R70 (2010).
   Google Scholar
• Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science318(5858), 1931–1934 (2007).
   PubMed Web of Science ®Google Scholar
• Eiring AM, Harb JG, Neviani P et al. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell140(5), 652–665 (2010).
   PubMed Web of Science ®Google Scholar
• Khraiwesh B, Arif MA, Seumel GI et al. Transcriptional control of gene expression by microRNAs. Cell140(1), 111–122 (2010).
   PubMed Web of Science ®Google Scholar
• O’Day E, Lal A. MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res.12(2), 201 (2010).
   PubMed Web of Science ®Google Scholar
• Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ.17(2), 193–199 (2010).
   PubMed Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell120(1), 15–20 (2005).
   PubMed Web of Science ®Google Scholar
• Scott GK, Goga A, Bhaumik D, Berger CE, Sullivan CS, Benz CC. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J. Biol. Chem.282(2), 1479–1486 (2007).
   PubMed Web of Science ®Google Scholar
• Barker A, Giles KM, Epis MR, Zhang PM, Kalinowski F, Leedman PJ. Regulation of ErbB receptor signalling in cancer cells by microRNA. Curr. Opin. Pharmacol.10(6), 655–661 (2010).
   PubMed Web of Science ®Google Scholar
• Chen D, Farwell MA, Zhang B. MicroRNA as a new player in the cell cycle. J. Cell. Physiol.225(2), 296–301 (2010).
   PubMed Web of Science ®Google Scholar
• Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. Modulation of microRNA processing by p53. Nature460(7254), 529–533 (2009).
   PubMed Web of Science ®Google Scholar
• Vecchione A, Croce CM. Apoptomirs: small molecules have gained the license to kill. Endocr. Relat. Cancer17(1), F37–F50 (2010).
   PubMed Web of Science ®Google Scholar
• Yu F, Yao H, Zhu P et al. Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell131(6), 1109–1123 (2007).
   PubMed Web of Science ®Google Scholar
• Lafferty-Whyte K, Cairney CJ, Jamieson NB, Oien KA, Keith WN. Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms. Biochim. Biophys. Acta.1792(4), 341–352 (2009).
   PubMed Web of Science ®Google Scholar
• Calin GA, Sevignani C, Dumitru CD et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl Acad. Sci. USA101(9), 2999–3004 (2004).
   PubMed Web of Science ®Google Scholar
• Lehmann U, Hasemeier B, Christgen M et al. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J. Pathol.214(1), 17–24 (2008).
   PubMed Web of Science ®Google Scholar
• Saito Y, Liang G, Egger G et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell9(6), 435–443 (2006).
   PubMed Web of Science ®Google Scholar
• Hsu PY, Deatherage DE, Rodriguez BA et al. Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res.69(14), 5936–5945 (2009).
   PubMed Web of Science ®Google Scholar
• Dedes KJ, Natrajan R, Lambros MB et al. Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. Eur. J. Cancer47(1), 138–150 (2011).
   PubMed Web of Science ®Google Scholar
• Adams BD, Claffey KP, White BA. Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells. Endocrinology150(1), 14–23 (2009).
   PubMed Web of Science ®Google Scholar
• Blenkiron C, Goldstein LD, Thorne NP et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome. Biol.8(10), R214 (2007).
   PubMed Web of Science ®Google Scholar
• Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, Klinge CM. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res.37(8), 2584–2595 (2009).
   PubMed Web of Science ®Google Scholar
• Leivonen SK, Makela R, Ostling P et al. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene28(44), 3926–3936 (2009).
   PubMed Web of Science ®Google Scholar
• Al-Nakhle H, Burns PA, Cummings M et al. Estrogen receptor {β} 1 expression is regulated by miR-92 in breast cancer. Cancer Res.70(11), 4778–4784 (2010).
   Google Scholar
• Tessel MA, Krett NL, Rosen ST. Steroid receptor and microRNA regulation in cancer. Curr. Opin. Oncol.22(6), 592–597 (2010).
   PubMedGoogle Scholar
• Kondo N, Toyama T, Sugiura H, Fujii Y, Yamashita H. miR-206 expression is down-regulated in estrogen receptor α-positive human breast cancer. Cancer Res.68(13), 5004–5008 (2008).
   PubMed Web of Science ®Google Scholar
• Adams BD, Furneaux H, White BA. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-α (ERα) and represses ERα messenger RNA and protein expression in breast cancer cell lines. Mol. Endocrinol.21(5), 1132–1147 (2007).
   PubMed Web of Science ®Google Scholar
• Bhat-Nakshatri P, Wang G, Collins NR et al. Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res.37(14), 4850–4861 (2009).
   PubMed Web of Science ®Google Scholar
• Yamagata K, Fujiyama S, Ito S et al. Maturation of microRNA is hormonally regulated by a nuclear receptor. Mol. Cell.36(2), 340–347 (2009).
   PubMed Web of Science ®Google Scholar
• Peter ME. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle8(6), 843–852 (2009).
   PubMed Web of Science ®Google Scholar
• Gregory PA, Bert AG, Paterson EL et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell. Biol.10(5), 593–601 (2008).
   PubMed Web of Science ®Google Scholar
• Cha ST, Chen PS, Johansson G et al. MicroRNA-519c suppresses hypoxia-inducible factor-1α expression and tumor angiogenesis. Cancer Res.70(7), 2675–2685 (2010).
   PubMed Web of Science ®Google Scholar
• Wu H, Zhu S, Mo YY. Suppression of cell growth and invasion by miR-205 in breast cancer. Cell. Res.19(4), 439–448 (2009).
   PubMed Web of Science ®Google Scholar
• Hurst DR, Edmonds MD, Welch DR. Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res.69(19), 7495–7498 (2009).
   PubMed Web of Science ®Google Scholar
• Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem.282(19), 14328–14336 (2007).
   PubMed Web of Science ®Google Scholar
• Huang Q, Gumireddy K, Schrier M et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell. Biol.10(2), 202–210 (2008).
   PubMed Web of Science ®Google Scholar
• Liu CG, Calin GA, Meloon B et al. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc. Natl Acad. Sci. USA101(26), 9740–9744 (2004).
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Miska EA et al. MicroRNA expression profiles classify human cancers. Nature435(7043), 834–838 (2005).
   PubMed Web of Science ®Google Scholar
• Chen C, Tan R, Wong L, Fekete R, Halsey J. Quantitation of microRNAs by real-time RT-qPCR. Methods Mol. Biol.687, 113–134 (2011).
   PubMedGoogle Scholar
• Li J, Smyth P, Flavin R et al. Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol.7, 36 (2007).
   PubMed Web of Science ®Google Scholar
• Iorio MV, Ferracin M, Liu CG et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res.65(16), 7065–7070 (2005).
   PubMed Web of Science ®Google Scholar
• Lowery AJ, Miller N, Devaney A et al. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res.11(3), R27 (2009).
   PubMed Web of Science ®Google Scholar
• Sempere LF, Christensen M, Silahtaroglu A et al. Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res.67(24), 11612–11620 (2007).
   PubMed Web of Science ®Google Scholar
• Van der Auwera I, Limame R, van Dam P, Vermeulen PB, Dirix LY, Van Laere SJ. Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype. Br. J. Cancer103(4), 532–541 (2010).
   Google Scholar
• Xiong J, Yu D, Wei N et al. An estrogen receptor α suppressor, microRNA-22, is downregulated in estrogen receptor α-positive human breast cancer cell lines and clinical samples. FEBS J.277(7), 1684–1694 (2010).
   PubMed Web of Science ®Google Scholar
• Lowery AJ, Miller N, Dwyer RM, Kerin MJ. Dysregulated miR-183 inhibits migration in breast cancer cells. BMC Cancer10, 502 (2010).
   Google Scholar
• Hui AB, Shi W, Boutros PC et al. Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab. Invest.89(5), 597–606 (2009).
   PubMed Web of Science ®Google Scholar
• Mattie MD, Benz CC, Bowers J et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol. Cancer5, 24 (2006).
   PubMed Web of Science ®Google Scholar
• Zhao JJ, Lin J, Yang H et al. MicroRNA-221/222 negatively regulates estrogen receptor α and is associated with tamoxifen resistance in breast cancer. J. Biol. Chem.283(45), 31079–31086 (2008).
   PubMed Web of Science ®Google Scholar
• Zhao Y, Deng C, Wang J et al. Let-7 family miRNAs regulate estrogen receptor α signaling in estrogen receptor positive breast cancer. Breast Cancer Res. Treat.127(1), 69–80 (2011).
   PubMed Web of Science ®Google Scholar
• Janssen EA, Slewa A, Gudlaugsson E et al. Biologic profiling of lymph node negative breast cancers by means of microRNA expression. Mod. Pathol.23(12), 1567–1576 (2010).
   PubMed Web of Science ®Google Scholar
• Yan LX, Huang XF, Shao Q et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA14(11), 2348–2360 (2008).
   PubMed Web of Science ®Google Scholar
• Qian B, Katsaros D, Lu L et al. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1. Breast Cancer Res. Treat.117(1), 131–140 (2009).
   PubMed Web of Science ®Google Scholar
• Huang GL, Zhang XH, Guo GL et al. Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma. Oncol. Rep.21(3), 673–679 (2009).
   PubMed Web of Science ®Google Scholar
• Wright JA, Richer JK, Goodall GJ. microRNAs and EMT in mammary cells and breast cancer. J. Mammary Gland Biol. Neoplasia15(2), 213–223 (2010).
   Google Scholar
• Baffa R, Fassan M, Volinia S et al. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J. Pathol.219(2), 214–221 (2009).
   PubMed Web of Science ®Google Scholar
• Valastyan S, Reinhardt F, Benaich N et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell137(6), 1032–1046 (2009).
   PubMed Web of Science ®Google Scholar
• Song B, Wang C, Liu J et al. MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. J. Exp. Clin. Cancer Res.29, 29 (2010).
   PubMedGoogle Scholar
• Camps C, Buffa FM, Colella S et al. hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin. Cancer Res.14(5), 1340–1348 (2008).
   PubMed Web of Science ®Google Scholar
• Mulrane LBD, McGee S, Jirström K et al. MiR-187 is a marker of poor prognosis in estrogen receptor-positive breast cancer. Presented at: 101 AACR 101st Annual Meeting 2010. Washington, DC, USA, 17–21 April 2010.
   Google Scholar
• McGee SML, Brennan D, McDonnell S, Jirstrom K, O’Connor D, Gallagher W. miR-224 is marker of poor prognosis in breast cancer. Presented at: AACR 101st Annual Meeting 2010. Washington, DC, USA, 17–21 April 2010.
   Google Scholar
• Tavazoie SF, Alarcon C, Oskarsson T et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature451(7175), 147–152 (2008).
   PubMed Web of Science ®Google Scholar
• Martello G, Rosato A, Ferrari F et al. A MicroRNA targeting dicer for metastasis control. Cell141(7), 1195–1207 (2010).
   PubMed Web of Science ®Google Scholar
• Foekens JA, Sieuwerts AM, Smid M et al. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc. Natl Acad. Sci. USA105(35), 13021–13026 (2008).
   PubMed Web of Science ®Google Scholar
• Ma J, Dong C, Ji C. MicroRNA and drug resistance. Cancer Gene. Ther.17(8), 523–531 (2010).
   PubMed Web of Science ®Google Scholar
• Iorio MV, Casalini P, Piovan C et al. MicroRNA-205 regulates HER3 in human breast cancer. Cancer Res.69(6), 2195–2200 (2009).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Gonzalez FG, Sieuwerts AM, Smid M et al. MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer. Breast Cancer Res. Treat.127(1), 43–51 (2011).
   PubMed Web of Science ®Google Scholar
• Rehman SH, Yu D. MiR-21 upregulation in breast cancer cells leads to PTEN loss and Herceptin resistance. Presented at: AACR 101st Annual Meeting 2010. Washington, DC, USA, 17–21 April 2010.
   Google Scholar
• Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliano AE, Hoon DS. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin. Chem.57(1), 84–91 (2011).
   PubMed Web of Science ®Google Scholar
• Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann. Surg.251(3), 499–505 (2010).
   PubMed Web of Science ®Google Scholar
• Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One5(10), e13735 (2010).
   PubMed Web of Science ®Google Scholar
• Criscitiello C, Sotiriou C, Ignatiadis M. Circulating tumor cells and emerging blood biomarkers in breast cancer. Curr. Opin. Oncol.22(6), 552–558 (2010).
   PubMedGoogle Scholar
• Stenvang J, Kauppinen S. MicroRNAs as targets for antisense-based therapeutics. Expert Opin. Biol. Ther.8(1), 59–81 (2008).
   PubMed Web of Science ®Google Scholar
• Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res.18(3), 350–359 (2008).
   PubMed Web of Science ®Google Scholar
• Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem.283(2), 1026–1033 (2008).
   PubMed Web of Science ®Google Scholar
• Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. miR-21-mediated tumor growth. Oncogene26(19), 2799–2803 (2007).
   PubMed Web of Science ®Google Scholar
• Blower PE, Chung JH, Verducci JS et al. MicroRNAs modulate the chemosensitivity of tumor cells. Mol. Cancer Ther.7(1), 1–9 (2008).
   PubMed Web of Science ®Google Scholar
• Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC. Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells. Oncogene27(42), 5643–5647 (2008).
   PubMed Web of Science ®Google Scholar
• Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res.69(4), 1279–1283 (2009).
   PubMed Web of Science ®Google Scholar
• Liang Z, Wu H, Reddy S et al. Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA. Biochem. Biophys. Res. Comm.363(3), 542–546 (2007).
   PubMed Web of Science ®Google Scholar
• Sachdeva M, Mo YY. miR-145-mediated suppression of cell growth, invasion and metastasis. Am. J. Transl. Res.2(2), 170–180 (2010).
   PubMed Web of Science ®Google Scholar
• Liang Z, Wu H, Xia J et al. Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem. Pharmacol.79(6), 817–824 (2010).
   PubMed Web of Science ®Google Scholar
• Grimm D, Streetz KL, Jopling CL et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature441(7092), 537–541 (2006).
   PubMed Web of Science ®Google Scholar
• Krutzfeldt J, Rajewsky N, Braich R et al. Silencing of microRNAs in vivo with ‘antagomirs’. Nature438(7068), 685–689 (2005).
   PubMed Web of Science ®Google Scholar
• Ma L, Reinhardt F, Pan E et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat. Biotechnol.28(4), 341–347 (2010).
   PubMed Web of Science ®Google Scholar
• Elmen J, Lindow M, Schutz S et al. LNA-mediated microRNA silencing in non-human primates. Nature452(7189), 896–899 (2008).
   PubMed Web of Science ®Google Scholar
• Lanford RE, Hildebrandt-Eriksen ES, Petri A et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science327(5962), 198–201 (2010).
   PubMed Web of Science ®Google Scholar
• Kota J, Chivukula RR, O’Donnell KA et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell137(6), 1005–1017 (2009).
   PubMed Web of Science ®Google Scholar
• Wiggins JF, Ruffino L, Kelnar K et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res.70(14), 5923–5930 (2010).
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhu X, Zhang X, Liu B, Huang L. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol. Ther.18(9), 1650–1656 (2010).
   PubMed Web of Science ®Google Scholar
• Davis ME, Zuckerman JE, Choi CH et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature464(7291), 1067–1070 (2010).
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell75(5), 843–854 (1993).
   PubMed Web of Science ®Google Scholar
• Sotiriou C, Pusztai L. Gene-expression signatures in breast cancer. N. Engl J. Med.360(8), 790–800 (2009).
   PubMed Web of Science ®Google Scholar
• Hossain A, Kuo MT, Saunders GF. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol. Cell. Biol.26(21), 8191–8201 (2006).
   PubMed Web of Science ®Google Scholar
• Yu Z, Wang C, Wang M et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J. Cell. Biol.182(3), 509–517 (2008).
   PubMed Web of Science ®Google Scholar
• Li H, Bian C, Liao L, Li J, Zhao RC. miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1. Breast Cancer Res. Treat.126(3), 565–575 (2010).
   Google Scholar
• Sachdeva M, Mo YY. miR-145-mediated suppression of cell growth, invasion and metastasis. Am. J. Transl. Res.2(2), 170–180 (2010).
   PubMed Web of Science ®Google Scholar
• Sun F, Fu H, Liu Q et al. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett.582(10), 1564–1568 (2008).
   PubMed Web of Science ®Google Scholar
• Qi L, Bart J, Tan LP et al. Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma. BMC Cancer9, 163 (2009).
   PubMed Web of Science ®Google Scholar
• Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res.67, 11001–11011 (2007).
   PubMed Web of Science ®Google Scholar
• Guttilla IK, White BA. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J. Biol. Chem.284(35), 23204–23216 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang L, Sullivan PS, Goodman JC, Gunaratne PH, Marchetti D. MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase. Cancer Res.71(3), 645–654 (2011).
   PubMed Web of Science ®Google Scholar
• Kong W, Yang H, He L et al. MicroRNA-155 is regulated by the transforming growth factor β/Smad pathway and contributes to epithelial cell plasticity by targeting ρA. Mol. Cell. Biol.28(22), 6773–6784 (2008).
   PubMed Web of Science ®Google Scholar
• Kong W, He L, Coppola M et al. MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J. Biol. Chem.285(23), 17869–17879 (2010).
   PubMed Web of Science ®Google Scholar
• Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature449(7163), 682–688 (2007).
   PubMed Web of Science ®Google Scholar
• Shen J, Ambrosone CB, DiCioccio RA, Odunsi K, Lele SB, Zhao H. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis29(10), 1963–1966 (2008).
   PubMed Web of Science ®Google Scholar
• Sharon F, McGee LM, Brennan DJ et al. miR-224 is marker of poor prognosis in breast cancer. Presented at: AACR 101st Annual Meeting 2010. Washington, DC, USA, 17–21 April 2010.
   Google Scholar
• Gee HE, Camps C, Buffa FM et al. MicroRNA-10b and breast cancer metastasis. Nature455(7216), E8–E9; author reply E9 (2008).
   Web of Science ®Google Scholar
• Yu F, Yao H, Zhu P et al. Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell131(6), 1109–1123 (2007).
   PubMed Web of Science ®Google Scholar